3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Specimen Handling
9
Tamoxifen
8
Radiotherapy
6
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Letrozole
3
Anastrozole
3
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Patient Navigation
2
Observation
2
Metformin
2
Mastectomy
2
Magnetic Resonance Spectroscopy
2
Genetic Testing
2
Biopsy
2
trastuzumab biosimilar HLX02
1
ruxolitinib
1
poly ICLC
1
palbociclib
1
fezolinetant
1
elacestrant
1
afimoxifene
1
abemaciclib
1
Trastuzumab
1
Testosterone
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
sargramostim
×
1 year
×
Clear all
No trials found.